You have 9 free searches left this month | for more free features.

sofosbuvir

Showing 1 - 25 of 431

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

Recruiting
  • HCV
  • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
  • Cairo, Egypt
    Faculty of Medicine, Ain-Shams University Research Institute-Cli
May 2, 2023

Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

Not yet recruiting
  • Hepatitis C
  • Cirrhosis
  • (no location specified)
Jul 20, 2022

Hepatitis C, Chronic, Pregnancy; Infection Trial in Pittsburgh (Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet)

Recruiting
  • Hepatitis C, Chronic
  • Pregnancy; Infection
  • Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
  • Denver, Colorado
  • +4 more
Dec 3, 2022

Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir

Not yet recruiting
  • Hepatitis C Infection
    • Beijing, Bejing, China
      Bejing Tsinghua Changgung Hospital
    Oct 31, 2022

    Cardiovascular Diseases, Hepatitis C, Hiv Trial in Washington, Baltimore (Elbasvir / Grazoprevir Oral Tablet [Zepatier], Cardiac

    Active, not recruiting
    • Cardiovascular Diseases
    • +2 more
    • Elbasvir / Grazoprevir Oral Tablet [Zepatier]
    • Cardiac MRI
    • Washington, District of Columbia
    • +1 more
    Feb 1, 2023

    Sofosbuvir/Daclatasvir in HCV-infected Lactating Women

    Recruiting
    • Hepatitis C Virus Infection
    • Pharmacokinetic test
    • Cairo, Non-US, Egypt
      Faculty of Medicine Ain Shams University Research Institute- Cli
    Aug 21, 2022

    Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)

    Completed
    • Hepatitis C, Chronic
    • Opioid-use Disorder
    • Pittsburgh, Pennsylvania
      Magee Womens Hospital of UPMC
    Aug 19, 2022

    Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

    Completed
    • Chronic Hepatitis c Genotype 1
    • Moscow, Russian Federation
    • +4 more
    Oct 27, 2022

    HCV Infection Trial in Phnom Penh (Sofosbuvir/Daclatasvir)

    Not yet recruiting
    • HCV Infection
    • Phnom Penh, Cambodia
      Clinical Trial Unit (Ctu)
    Aug 7, 2023

    Liver Transplant, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)

    Active, not recruiting
    • Liver Transplant
    • Hepatitis C
    • Pittsburgh, Pennsylvania
      UPMC
    Oct 6, 2022

    Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))

    Recruiting
    • Hepatitis C
    • Sofosbuvir 400mg [Sovaldi]
    • Glecaprevir/pibrentasvir (300mg/120mg)
    • Darlinghurst, New South Wales, Australia
    • +2 more
    Mar 28, 2022

    HCV Coinfection, Liver Disease, HIV Trial in Baltimore (Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX],

    Completed
    • HCV Coinfection
    • +2 more
    • Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
    • Sofosbuvir/Velpatasvir (SOF/VEL)
    • Baltimore, Maryland
      Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
    Feb 10, 2022

    Hepatitis B Trial in Baltimore (Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni], Sofosbuvir 400 MG [Sovaldi],

    Completed
    • Hepatitis B
    • Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni]
    • +2 more
    • Baltimore, Maryland
      Institute of Human Virology (IHV), University of Maryland Baltim
    Aug 24, 2021

    Hepatitis C, Chronic Trial in Mansoura (Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet)

    Completed
    • Hepatitis C, Chronic
    • Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet
    • Mansoura, Egypt
      Mansoura University Children Hospital
    Oct 21, 2021

    Hepatitis C, Awaiting Organ Transplant Trial in Boston (Sofosbuvir/velpatasvir, Monitoring)

    Recruiting
    • Hepatitis C
    • Awaiting Organ Transplant
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Mar 14, 2022

    Covid19, SARS-CoV Infection Trial in Johannesburg (Nitazoxanide, Sofosbuvir/Daclatasvir)

    Completed
    • Covid19
    • SARS-CoV Infection
    • Johannesburg, Gauteng, South Africa
    • +1 more
    Jun 6, 2022

    Hepatitis C, Chronic Trial in Pittsburgh (Sofosbuvir-Velpatasvir Drug Combination)

    Recruiting
    • Hepatitis C, Chronic
    • Sofosbuvir-Velpatasvir Drug Combination
    • Pittsburgh, Pennsylvania
      University of Pittsburgh, Magee Womens Hospital
    Sep 3, 2021

    Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))

    Terminated
    • Hepatitis C
    • Simeprivir (SMV)
    • +2 more
    • Denver, Colorado
      University of Colorado Denver (Leprino Building)
    Aug 16, 2021

    Male Infertility, HCV Trial in Al Qalyubiyah, Banha (Sofosbuvir +daclatasvir+ simeprevir+Ribavirin)

    Recruiting
    • Male Infertility
    • HCV
    • Sofosbuvir +daclatasvir+ simeprevir+Ribavirin
    • Al Qalyūbīyah, Benha, Egypt
    • +1 more
    Nov 7, 2022

    Elimination of Hepatitis C Virus Among Users of Substances

    Not yet recruiting
    • Hepatitis C in Substance Users
    • Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]
    • (no location specified)
    Aug 14, 2022

    Chronic Hepatitis C, People Who Inject Drugs Trial in Atlanta (velpatasvir and sofosbuvir once daily for 12 weeks (brand or

    Active, not recruiting
    • Chronic Hepatitis C
    • People Who Inject Drugs
    • velpatasvir and sofosbuvir once daily for 12 weeks (brand or branded generic) .
    • Atlanta, Georgia
      Wellstar Atlanta Medical Center
    May 31, 2023

    Hepatitis C Treatment Study in Myanmar

    Withdrawn
    • Hepatitis C
    • Sofosbuvir 400 mg
    • Yangon, Myanmar
      Medical Action Myanmar
    Dec 3, 2021

    Kidney Transplantation, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)

    Active, not recruiting
    • Kidney Transplantation
    • Hepatitis C
    • Pittsburgh, Pennsylvania
      UPMC
    Oct 27, 2021

    Kidney Failure, Chronic, Hepatitis C Trial in Lucknow (Sofosbuvir, Daclatasvir 60 mg)

    Completed
    • Kidney Failure, Chronic
    • Hepatitis C
    • Sofosbuvir
    • Daclatasvir 60 mg
    • Lucknow, Uttar Pradesh, India
      Sanjay Gandhi Postgraduate Institute of Medical Sciences
    Apr 4, 2021